Pharming Group
PHAR
6 hedge funds and large institutions have $2.17M invested in Pharming Group in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 3 → 6 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
12% less capital invested
Capital invested by funds: $2.46M → $2.17M (-$298K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$158K |
| 2 |
CPA
Cowen Prime Advisors
New York
|
+$78.4K |
| 3 |
Morgan Stanley
New York
|
+$31.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$254K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JAM
1
JW Asset Management
Miami Beach,
Florida
| $1.91M | -$254K | -20,368 | -11% |
|
|
2
Jane Street
New York
| $144K | +$158K | +12,674 | New |
|
|
CPA
3
Cowen Prime Advisors
New York
| $71K | +$78.4K | +6,300 | New |
|
|
4
Morgan Stanley
New York
| $29K | +$31.1K | +2,500 | +5,208% |
|
|
5
UBS Group
Zurich,
Switzerland
| $15K | -$14.8K | -1,189 | -47% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1K | +$1.11K | +89 | New |
|
PHAR Hedge Fund Activity: Q2 2021 in Review
6 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q2 2021, worth a combined $2.17M — down 12% from $2.46M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PHAR positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $158K. The largest seller was JW Asset Management, cutting an estimated $254K.
- 6 institutional investors held Pharming Group (PHAR) as of Q2 2021, up from 3 in Q1 2021.
- Funds reported $2.17M of Pharming Group stock for Q2 2021, down 12% quarter-over-quarter.
- 3 funds opened new Pharming Group positions in Q2 2021 and 0 closed out, a net change of +3 holders.
- The largest Pharming Group buyer in Q2 2021 was Jane Street, an estimated $158K added.
- The largest Pharming Group seller in Q2 2021 was JW Asset Management, an estimated $254K sold.
Based on aggregated 13F filings for Q2 2021.